- Previous Close
163.70 - Open
160.45 - Bid --
- Ask 160.45 x --
- Day's Range
160.45 - 160.45 - 52 Week Range
72.51 - 202.80 - Volume
2,979 - Avg. Volume
29,085 - Market Cap (intraday)
4.211B - Beta (5Y Monthly) 1.54
- PE Ratio (TTM)
-- - EPS (TTM)
-7.69 - Earnings Date Jan 29, 2025 - Feb 3, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Brooks Laboratories Limited manufactures and sells pharmaceuticals in India and internationally. The company offers liquid and dry powder injection, carbapenem dry powder injectables, tablets, oral suspension, dry syrup, and eye/ear drops. Brooks Laboratories Limited was incorporated in 2002 and is based in Mumbai, India.
www.brookslabs.net293
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: BROOKS.BO
View MorePerformance Overview: BROOKS.BO
Trailing total returns as of 1/21/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BROOKS.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BROOKS.BO
View MoreValuation Measures
Market Cap
4.30B
Enterprise Value
4.36B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.46
Price/Book (mrq)
7.26
Enterprise Value/Revenue
5.61
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-21.46%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
817.16M
Net Income Avi to Common (ttm)
-175.35M
Diluted EPS (ttm)
-7.69
Balance Sheet and Cash Flow
Total Cash (mrq)
6.93M
Total Debt/Equity (mrq)
8.60%
Levered Free Cash Flow (ttm)
--